VEGFA + 936C>T polymorphism and cancer risk: A meta-analysis

Cancer Genetics and Cytogenetics

Volumn 198, Issue 1, 2010, Pages 7-14

  Xu, Bin ^a,b   Li, Jiu Ming ^c   Tong, Na ^b   Tao, Jun ^a   Li, Peng Chao ^a   Song, Ning Hong ^a   Zhang, Wei ^a   Wu, Hong Fei ^c   Feng, Ning Han ^a   Hua, Li Xin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED BENQ HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; THREONINE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; GENETIC ASSOCIATION; HUMAN; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; GENETIC POLYMORPHISM; GENETICS; META ANALYSIS; MOUTH TUMOR; RISK;

HUMANS; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950359852     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.007     Document Type: Article

References (39)

1. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002, 2:795-803.
4. Chae Y.S., Kim J.G., Sohn S.K., Cho Y.Y., Moon J.H., Bae H.I., Park J.Y., Lee M.H., Lee H.C., Chung H.Y., Yu W. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 2006, 71:266-272.
5. Dassoulas K., Gazouli M., Rizos S., Theodoropoulos G., Christoni Z., Nikiteas N., Karakitsos P. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009, 48:563-569.
6. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000, 37:443-448.
7. Bae S.J., Ahn D.H., Hong S.P., Kang H., Hwang S.G., Oh D., Kim N.K. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J 2008, 49:783-791.
8. Yapijakis C., Vairaktaris E., Vassiliou S., Vylliotis A., Nkenke E., Nixon A.M., Derka S., Spyridonidou S., Vorris E., Neukam F., Patsouris E. The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 2007, 133:787-791.
9. Krippl P., Langsenlehner U., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., Paulweber B., Haas J., Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003, 106:468-471.
10. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
11. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
12. Abe A., Sato K., Habuchi T., Wang L., Li Z., Tsuchiya N., Ohyama C., Satoh S., Ogawa O., Kato T. Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 2002, 198:181-190.
13. Howell W.M., Bateman A.C., Turner S.J., Collins A., Theaker J.M. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002, 3:229-232.
14. Jin Q., Hemminki K., Enquist K., Lenner P., Grzybowska E., Klaes R., Henriksson R., Chen B., Pamula J., Pekala W., Zientek H., Rogozinska-Szczepka J., Utracka-Hutka B., Hallmans G., Försti A. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005, 11:3647-3653.
15. Eroglu A., Gulec S., Kurtman C., Cam R., Akar N. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 2006, 17:1467-1468.
16. Jacobs E.J., Feigelson H.S., Bain E.B., Brady K.A., Rodriguez C., Stevens V.L., Patel A.V., Thun M.J., Calle E.E. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006, 8:R22.
17. Kataoka N., Cai Q., Wen W., Shu X.O., Jin F., Gao Y.T., Zheng W. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006, 15:1148-1152.
18. Sfar S., Hassen E., Saad H., Mosbah F., Chouchane L. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 2006, 35:21-28. [Erratum in: Cytokine 2006;36:199-200].
19. Balasubramanian S.P., Cox A., Cross S.S., Higham S.E., Brown N.J., Reed M.W. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007, 121:1009-1016.
20. García-Closas M., Malats N., Real F.X., Yeager M., Welch R., Silverman D., Kogevinas M., Dosemeci M., Figueroa J., Chatterjee N., Tardón A., Serra C., Carrato A., García-Closas R., Murta-Nascimento C., Rothman N., Chanock S.J. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007, 3:e29.
21. Hsiao P.J., Lu M.Y., Chiang F.Y., Shin S.J., Tai Y.D., Juo S.H. Vascular endothelial growth factor gene polymorphisms in thyroid cancer. J Endocrinol 2007, 195:265-270.
22. Jakubowska A., Gronwald J., Menkiszak J., Górski B., Huzarski T., Byrski T., Edler L. Lubiński J, Scott RJ, Hamann U. The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2007 Dec. 31, [Epub ahead of print].
23. Konac E., Onen H.I., Metindir J., Alp E., Biri A.A., Ekmekci A. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers. DNA Cell Biol 2007, 26:453-463.
24. Nikiteas N.I., Tzanakis N., Theodoropoulos G., Atsaves V., Christoni Z., Karakitsos P., Lazaris A.C., Papachristodoulou A., Klonaris C., Gazouli M. Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer 2007, 10:12-17.
25. Amano M., Yoshida S., Kennedy S., Takemura N., Deguchi M., Ohara N., Maruo T. Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population. Eur J Gynaecol Oncol 2008, 29:333-337.
26. Bae S.J., Kim J.W., Kang H., Hwang S.G., Oh D., Kim N.K. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008, 28:1271-1276.
27. Chae Y.S., Kim J.G., Sohn S.K., Cho Y.Y., Ahn B.M., Moon J.H., Jeon S.W., Park J.Y., Lee I.T., Choi G.S., Jun S.H. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 2008, 23:421-427.
28. Cheng C.Y., Chang C.S., Liu C.J., Kao S.Y. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:79-84.
29. Hofmann G., Langsenlehner U., Renner W., Langsenlehner T., Yazdani-Biuki B., Clar H., Gerger A., Wehrschuetz M., Samonigg H., Krippl P. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 2008, 134:591-595.
30. Hsing A.W., Sakoda L.C., Rashid A., Andreotti G., Chen J., Wang B.S., Shen M.C., Chen B.E., Rosenberg P.S., Zhang M., Niwa S., Chu L., Welch R., Yeager M., Fraumeni J.F., Gao Y.T., Chanock S.J. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 2008, 68:6442-6452.
31. Ke Q., Liang J., Wang L.N., Hu Z.B., Jin G.F., Zhou Y., Wang J.M., Tan Y.F., Hua Z.L., Xu Y.C., Shen J., Shen H.B. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 2008, 47:647-651.
32. Zhai R., Liu G., Asomaning K., Su L., Kulke M.H., Heist R.S., Nishioka N.S., Lynch T.J., Wain J.C., Lin X., Christiani D.C. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 2008, 29:2330-2334.
33. Zhai R., Liu G., Zhou W., Su L., Heist R.S., Lynch T.J., Wain J.C., Asomaning K., Lin X., Christiani D.C. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res 2008, 14:612-617.
34. Al-Moundhri M.S., Al-Nabhani M., Burney I.A., Al-Farsi A.A., Al-Bahrani B. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms: a case-control study in an Omani population. Mol Carcinog 2009 Aug. 12, [Epub ahead of print].
35. Tahara T., Shibata T., Nakamura M., Yamashita H., Yoshioka D., Hirata I., Arisawa T. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog 2009, 48:1030-1037.
36. Wu G.Y., Hasenberg T., Magdeburg R., Bönninghoff R., Sturm J.W., Keese M. Association between EGF, TGF-β1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009, 33:124-129.
37. Guba M., Seeliger H., Kleespies A., Jauch K.W., Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis 2004, 19:510-517.
38. McCarron S.L., Edwards S., Evans P.R., Gibbs R., Dearnaley D.P., Dowe A., Southgate C., Easton D.F., Eeles R.A., Howell W.M. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002, 62:3369-3372.
39. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., Spitz M.R. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000, 92:1764-1772.